期刊文献+

再灌注预处理对急性心肌梗死患者的影响 被引量:5

Effect of reperfusion preconditioning on acute myocardial infarction
原文传递
导出
摘要 目的探讨急诊经皮冠状动脉介入术(percutaneous coronary intervention,PCI)治疗时再灌注预处理对急性心肌梗死患者的影响。方法 87例急性心肌梗死患者行急诊PCI时,45例于支架植入前行低流量灌注10min(预处理组),42例直接行球囊扩张和支架植入(对照组)。观察2组支架植入后罪犯血管无复流发生率、再灌注心律失常、心肌损伤标志物水平和心功能变化。结果预处理组支架植入后罪犯血管无复流发生率(6.7%)低于对照组(16.7%)(P<0.01),术中及术后2h内再灌注心律失常发生率(24.4%)低于对照组(40.1%)(P<0.01),血清肌酸激酶同工酶峰值(52.5±19.4)μg/L低于对照组(66.8±22.9)μg/L(P<0.05),术后第7天左心室射血分数(55±12)%高于对照组(48±13)%(P<0.05)。结论急性心肌梗死患者行急诊PCI时采用低流量灌注进行再灌注预处理可减少心肌再灌注损伤,提高治疗效果。 Objective To evaluate the effect of reperfusion preconditioning on the patients with acute myocardial infarction (AMI) during primary percutaneous coronary intervention (PCI). Methods A total of 87 patients with AMI receiving primary PCI were divided into preconditioning group (n=45) receiving preconditioning with low-flow perfusion for 10 minutes before stent implantation, and control group (n=42) directly receiving balloon dilatation and stent implantation without preconditioning. The incidences of no-reflow, reperfusion arrhythmias, myocardial injury marker levels and cardiac function were recorded after stent implantation. Results The incidence of no-reflow was significantly lower in preconditioning group (6.7%) than that in control group (16. 7%) (P〈0.01). The incidence of reperfusion arrhythmias was significantly lower in preconditioning group (24. 4 %) than that in control group (40. 1 % ) during PCI and 2 hours after PCI (P〈0.01). The creatine kinase-myocardial band peak was (52.5±19.4) ug/L in preconditioning group significantly lower than that in control group (66.8±22.9) ug/L (P〈0.05). The left ventricular ejection fraction was significantly higher in preconditioning group (0.55±0.12) than that in control group (0.48±0.13) 7 days after PCI (P〈0.05). Conclusion During primary PCI, reperfusion preconditioning with low-flow perfusion can reduce myocardial reperfusion injury, and enhance the therapeutic effect.
出处 《中华实用诊断与治疗杂志》 2012年第10期989-990,共2页 Journal of Chinese Practical Diagnosis and Therapy
关键词 急性心肌梗死 经皮冠状动脉介入治疗 再灌注预处理 Acute myocardial infarction percutaneous coronary intervention reperfusion preconditioning
  • 相关文献

参考文献9

  • 1Zhao Z Q, Corvera J S, Halkos M E, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning[J]. Am J Physiol Heart Circ Physio1,2003,285(2) : 579- 588.
  • 2Staat P, Rioufol G, Piot C, et al. Postconditioning the human heart[J]. Circulation, 2005,112 ( 14): 2143-2148.
  • 3高润霖.急性心肌梗死诊断和治疗指南[J].中华心血管病杂志,2001,29(12):710-725. 被引量:4988
  • 4Murry C E, Jennings R B, Reimer K A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium [J]. Circulation, 1986,74(5): 1124-1136.
  • 5Morlshima I, Sone T, Okumura K, et al. Angiographic no- fellow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction[J]. J Am Coll Cardiol,2000,36 (4) : 1202-1209.
  • 6张倩,王春梅,张立新,朱小玲,李响,刘子军.艾司洛尔对急性心肌梗死再灌注心律失常的影响[J].中华实用诊断与治疗杂志,2010,24(12):1179-1181. 被引量:9
  • 7马双陶,杨大春,李刚,李德,唐兵,杨永健.血浆一氧化氮在酒精性心肌病评估中作用[J].中华实用诊断与治疗杂志,2011,25(7):647-649. 被引量:5
  • 8Kin H, Zhao Z Q, Sun H Y, etal. Postconditioning attenuates myocardial isehemia reperfusion injury by inhibiting events in the early minutes of reperfusion[J]. Cardiovasc Res, 2004,62 (1) :74-85.
  • 9杨新春,刘宇,王乐丰,葛永贵,王红石,李惟铭,徐立,崔亮,徐琳,王铁,刘胜辉,贾慧敏.心脏缺血后适应减轻急性心肌梗死再灌注损伤临床研究[J].中国介入心脏病学杂志,2006,14(6):323-326. 被引量:21

二级参考文献29

  • 1单兆亮 王玉堂 王思让 等.艾司洛尔对犬急性心肌梗死后再灌注性心律失常的预防作用.中华心血管病杂志,1998,26(3):230-1.
  • 2Jingjun L, Yan Z, Weijie, et al. Effect and mechanism of esmolol given during cardiopulmonary resuscitation in a porcine ventricular fibrillation model [J]. Resuscitation, 2009, 80 (9) : 1052-1059.
  • 3The Esmolol Research Group. Intravenous esmolol for the treatment of Supra ventricular tachyarrhythmia: results of a multicenter baseline controlled safety and efficiency study in 160 patients[J]. Am Heart J,2003,11(2):498- 505.
  • 4Lange R, Kloner R A, Braunwald E. First ultra-short acting beta adrenergic blocking agent= its effect on size and segmental wall dynamics of reperfused myocardial infarcts in dogs[J]. Am J Cardiol,1983,5(11) :1759 -1767.
  • 5Reil J C, Bohm M. The role of heart rate in the development of cardiovascular disease[J]. Clin Res Cardiol, 2007,96 (9) :585- 592.
  • 6Bauer A, Kantelhardt J W, Barthel P, et al. Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort-study[J]. Lancet, 2006, 367 (9523):1674- 1681.
  • 7Zhang X, Li S Y, Brown R A, etal. Ethanol and acetaldehyde in alcoholic cardiomyopathy: from bad to ugly en route to oxidative stress[J]. Alcohol, 2004,32 (3) : 175-186.
  • 8Kajiya M, Hirota M, Inai Y, et al. Impaired NO-mediated vasodilation with increased superoxide but robust EDHF function in right ventricular arterial microvessels of pulmonary hypertensive rats[J]. Am J Physiol Heart Circ Physiol,2007, 292(6) :2737-2744.
  • 9Bonaventura J, Gow A. NO and superoxide: opposite ends of the seesaw in cardiac contractility[J]. Proc Natl Acad Sei USA, 2004,101(47) :16403-16404.
  • 10Bagi Z, Koller A, Kaley G. Superoxide-NO interaction decreases flow and agonist induced dilations of coronary arterioles in type 2 diabetes mellitus[J]. Am J Physiol Heart Circ Physiol,2003,285(4) : 1404-1410.

共引文献5013

同被引文献50

  • 1郭显湖,任远.BNP在心血管疾病中的研究进展[J].河北医学,2005,11(3):285-288. 被引量:3
  • 2刘学慧,王静,温素云,张建明.大剂量胺碘酮在急性心肌梗死并发顽固性室性心律失常中的应用[J].中华急诊医学杂志,2005,14(9):763-764. 被引量:11
  • 3陈纪林.急性冠状动脉综合征再灌注治疗和抗栓治疗的进展[J].中国循环杂志,2006,21(1):67-68. 被引量:9
  • 4蔡自力,党瑜华.心电图诊断急性心肌梗死的新进展[J].实用诊断与治疗杂志,2007,21(1):54-55. 被引量:14
  • 5Matetzky S, Shenkman B, Guetta V, et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotie events in patients with acute myocardial infarction[J]. Circulation,2004,109(25) :3171 -3175.
  • 6Barragan P, Bouvier J L, Roquebert P O, et al. Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulat ed phosphoprotein phosphorylation[J].Catheter Cardiovasc Interv, 2003, 59 (3) : 295 -302.
  • 7Kim H, Lee H K, Han K, etal. Prevalence and risk factors for aspirin and clopidogrel resistance in patients with coronary artery disease or ischemic cerebrovascular disease[J]. Am Clin Lab, 2009,39 (3) :289-294.
  • 8Guyer K E. The present state of aspirin and clopidogrel resistance[J]. Hamostaseologie, 2009,29 (3) : 285-290.
  • 9Preis S R, Hwang S J, Coady S, et al. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005[J]. Circulation,2009,119(13) :1728- 1735.
  • 10Cotton J M, Worrall A M, Hobson A R, et al. Individualised assessment of response to clopidogrel in patients presenting with acute coronary syndromes: a role for short thrombelastography [J].CardiovascTher,2010,28(3):139- 146.

引证文献5

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部